Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tyche Industries's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹-1.7 Mil.
Tyche Industries's average Total Assets over the quarter that ended in Jun. 2026 was ₹1,480.4 Mil. Therefore, Tyche Industries's annualized ROA % for the quarter that ended in Jun. 2026 was -0.11%.
The historical rank and industry rank for Tyche Industries's ROA % or its related term are showing as below:
BOM:532384'
s ROA % Range Over the Past 10 Years
Min: 2.97 Med: 9.1 Max: 20.81
Current: 2.97
During the past 13 years, Tyche Industries's highest ROA % was 20.81%. The lowest was 2.97%. And the median was 9.10%.
BOM:532384's ROA % is ranked better than 51.99% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 2.685
vs BOM:532384: 2.97
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Tyche Industries ROA % Related Terms
Tyche Industries ROA % Historical Data
* Premium members only.
The historical data trend for Tyche Industries's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tyche Industries's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tyche Industries ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tyche Industries's ROA % distribution charts can be found below:
* The bar in red indicates where Tyche Industries's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Tyche Industries (BOM:532384) has a ROA % of -0.11% as of Jun. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tyche Industries and its competitors. Over the past decade, Tyche Industries' ROA % has ranged from 2.97 to 20.81. According to the industry distribution chart, Tyche Industries ranks #483 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 48%.
Is Tyche Industries' ROA % too high?
Tyche Industries' current ROA % is -0.11%. Over the past 10 years, this metric has ranged from a low of 2.97 to a high of 20.81. Based on the distribution chart, Tyche Industries ranks #483 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Tyche Industries has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tyche Industries' ROA % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Tyche Industries ranks #483 out of 1006 companies for ROA %. This puts Tyche Industries in the upper half of its industry. The industry median ROA % is 2.69. Historically, Tyche Industries' own ROA % has ranged from 2.97 to 20.81 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tyche Industries and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tyche Industries's current ROA % is -0.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tyche Industries stock overvalued right now?
Based on GuruFocus' analysis, Tyche Industries (BOM:532384) is currently considered Fairly Valued. The stock's GF Value™ is ₹108.23, compared to a current price of ₹106.85 — trading 1.3% below its estimated fair value. The current ROA % is -0.11%. Tyche Industries' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Tyche Industries (BOM:532384), the current ROA % is -0.11% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tyche Industries (BOM:532384) Overvalued in 2026?
Based on GuruFocus' analysis, Tyche Industries stock appears to be undervalued.
The current stock price of ₹106.85 is trading 1.3% below its estimated GF Value™ of ₹108.23.
GuruFocus considers Tyche Industries to be Fairly Valued.
Key valuation signals for BOM:532384:
ROA %: -0.11%
GF Value™: ₹108.23 vs. price of ₹106.85 (1.3% below fair value)
No single metric tells the full story. See the BOM:532384 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tyche Industries Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing of bulk drug intermediates. Geographically, it derives a majority of its revenue from the Export business. The company is a manufacturer in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to the USA and Europe. Its business areas include API, Intermediates, Chiral Intermediates, Nutraceuticals, and CDMO. It operates in a single segment namely the manufacture of bulk drugs intermediates.
72GF Score
Get the complete analysis for BOM:532384
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532384 has been successfully added to your 
